Literature DB >> 32980898

Bone Microthrombus Promotes Bone Loss in Iron Accumulation Rats.

Hai-Feng Hang1,2, Long-Jia Dong1,3, Xin-Bing Tang2, Ai-Fei Wang1, Fan Yang1,4, Hui Zhang1, You-Jia Xu5,6.   

Abstract

In the present study, we investigated the changes of the coagulation state, bone microthrombus, microvascular bed and bone density levels in iron accumulation rats. Meanwhile,the effect of anticoagulation therapy on bone mineral density was further investigated. We established two groups: a control (Ctrl) group and an iron intervention (FAC) group. Changes in coagulation function, peripheral blood cell counts, bone microthrombus, bone vessels and bone mineral density were compared between the two groups. We designed the non-treatment group and treatment group to study the changes of bone mineral density by preventing microthrombus formation with the anticoagulant fondaparinux. We found that the fibrinogen and D-dimer contents were significantly higher, whereas the thrombin time (TT) and prothrombin time (PT) were significantly shorter in the FAC group. After ink staining, the microvascular bed in the FAC group was significantly reduced compared with that in the Ctrl group. HE and Martius Scarlet Blue (MSB) staining showed microthrombus in the bone marrow of the iron accumulation rats. Following anticoagulation therapy, the bone microcirculation vascular bed areas in the treatment group rats were significantly increased. Furthermore, the bone mineral density was increased in the treatment group compared with that in the non-treatment group. Through experiments, we found that the blood in iron accumulation rat was relatively hypercoagulable; moreover, there was microthrombus in the bone marrow, and the bone vascular bed was reduced. Additionally, anticoagulation was helpful for improving bone microcirculation, reducing microthrombus and decreasing bone loss.

Entities:  

Keywords:  anticoagulant; bone microthrombus; coagulation state; iron accumulation; microvascular bed; osteoporosis

Mesh:

Substances:

Year:  2020        PMID: 32980898     DOI: 10.1007/s11596-020-2251-8

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  41 in total

1.  Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study.

Authors:  Beom-Jun Kim; Seong Hee Ahn; Sung Jin Bae; Eun Hee Kim; Seung-Hun Lee; Hong-Kyu Kim; Jae Won Choe; Jung-Min Koh; Ghi Su Kim
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

2.  Bone mass density in adults with sickle cell disease.

Authors:  Mona Sarrai; Herold Duroseau; Jean D'Augustine; Sabita Moktan; Rita Bellevue
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998

Review 3.  Iron loading: a risk factor for osteoporosis.

Authors:  E D Weinberg
Journal:  Biometals       Date:  2006-04-29       Impact factor: 2.949

4.  Bone mineral density in men with genetic hemochromatosis and HFE gene mutation.

Authors:  P Guggenbuhl; Y Deugnier; J F Boisdet; Y Rolland; A Perdriger; Y Pawlotsky; G Chalès
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

5.  Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.

Authors:  T P Tuomainen; K Kontula; K Nyyssönen; T A Lakka; T Heliö; J T Salonen
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

6.  Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women.

Authors:  M Roest; Y T van der Schouw; B de Valk; J J Marx; M J Tempelman; P G de Groot; J J Sixma; J D Banga
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

Review 7.  Iron-mediated cardiovascular injury.

Authors:  L D Horwitz; E A Rosenthal
Journal:  Vasc Med       Date:  1999       Impact factor: 3.239

8.  Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes.

Authors:  B de Valk; M A Addicks; I Gosriwatana; S Lu; R C Hider; J J Marx
Journal:  Eur J Clin Invest       Date:  2000-03       Impact factor: 4.686

9.  Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.

Authors:  Sharlene M Day; Damon Duquaine; Lakshmi V Mundada; Rekha G Menon; Bobby V Khan; Sanjay Rajagopalan; William P Fay
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

10.  High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

Authors:  J T Salonen; K Nyyssönen; H Korpela; J Tuomilehto; R Seppänen; R Salonen
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.